Status:
COMPLETED
Severe Necrotizing Enterocolitis in Preterm Newborns <1500g Using Probiotics
Lead Sponsor:
Coordinación de Investigación en Salud, Mexico
Conditions:
Infectious Diseases
Eligibility:
All Genders
27-34 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to know the effects of probiotics on the incidence of Necrotizing Enterocolitis (NEC) in preterm infants less than 1500 g.
Detailed Description
The investigators performed a clinical, randomized, double-blind trial in preterm infants \<1500g from March 1, 2010 to February 28, 2012. Group A received enteral stimulation trophic five days and la...
Eligibility Criteria
Inclusion
- We studied 150 preterm newborns \<1500gr who were recruited on the day that began enteral feeding according to the decision of the treating physician.
Exclusion
- Preterm infants \> 1500g with Apgar score \<6 at 5 minutes, gastrointestinal malformations, fetopathies, patent ductus arteriosis with hemodynamic decompensation, asphyxia, and NEC suspected as classified by Bell were excluded from the study.
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT02226263
Start Date
March 1 2010
End Date
February 1 2012
Last Update
August 27 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Mexicano del seguro social
León, Guanajuato, Mexico, 37000